Evidence map›Paper›PMID 37829547›Full record

ArticleIsrael journal of chemistry2023

Re-Imagining Drug Discovery using Mass Spectrometry.

R Graham Cooks, Yunfei Feng, Kai-Hung Huang, Nicolás M Morato, Lingqi Qiu

Abstract read
In one paragraph

Article in Israel journal of chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Accelerated Chemistry in Microdroplets.Accounts of chemical research · 2026
    Article
  2. Article
  3. Article
  4. Early-stage drug discovery in a new-generation ultrahigh-throughput mass spectrometry platform.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Review
  7. Accelerating countermeasure candidate discovery for A-series chemical warfare agent exposure.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R Graham CooksDepartment of Chemistry and Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907 USA.
Yunfei FengDepartment of Chemistry and Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907 USA.
Kai-Hung HuangDepartment of Chemistry and Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907 USA.
Nicolás M MoratoDepartment of Chemistry and Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907 USA.
Lingqi QiuDepartment of Chemistry and Bindley Bioscience Center, Purdue University, West Lafayette, IN 47907 USA.

Funding

High throughput infrastructure for reaction screening and bioassaysUG3TR004139 · NCATS · PURDUE UNIVERSITY · PI COOKS, ROBERT GRAHAM · 2022 to 2023
$1.8M
NCATS NIH HHS UG3 TR004139
6 · The paper itself

Abstract

It is argued that each of the three key steps in drug discovery, (i) reaction screening to find successful routes to desired drug candidates, (ii) scale up of the synthesis to produce amounts adequate for testing, and (iii) bioactivity assessment of the candidate compounds, can all be performed using mass spectrometry (MS) in a sequential fashion. The particular ionization method of choice, desorption electrospray ionization (DESI), is both an analytical technique and a procedure for small-scale synthesis. It is also highly compatible with automation, providing for high throughput in both synthesis and analysis. Moreover, because accelerated reactions take place in the secondary DESI microdroplets generated from individual reaction mixtures, this allows either online analysis by MS or collection of the synthetic products by droplet deposition. DESI also has the unique advantage, amongst spray-based MS ionization methods, that complex buffered biological solutions can be analyzed directly, without concern for capillary blockage. Here, all these capabilities are illustrated, the unique chemistry at droplet interfaces is presented, and the possible future implementation of DESI-MS based drug discovery is discussed.

Indexed as

automationbioanalyticalDesorption electrospray ionizationhigh-throughput screeninglate-stage functionalizationtandem mass spectrometry

Identifiers

PMID37829547
PMCPMC10569432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.